Kreuwel HT - Search Results

1

Hospital economic impact from hemostatic matrix usage in cardiac surgery.

Tackett SM, Sugarman R, Kreuwel HT, Alvarez P, Nasso G. Tackett SM, et al. Among authors: kreuwel ht. J Med Econ. 2014 Sep;17(9):670-6. doi: 10.3111/13696998.2014.928638. Epub 2014 Jun 20. J Med Econ. 2014. PMID: 24927164 Free article. Clinical Trial.

2

Comparison of hemostatic matrix and standard hemostasis in patients undergoing primary TKA.

Comadoll JL, Comadoll S, Hutchcraft A, Krishnan S, Farrell K, Kreuwel HT, Bechter M. Comadoll JL, et al. Among authors: kreuwel ht. Orthopedics. 2012 Jun;35(6):e785-93. doi: 10.3928/01477447-20120525-14. Orthopedics. 2012. PMID: 22691647 Clinical Trial.

3

Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease.

Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, Mackersie RC, Rodas A, Kreuwel HT, Harris HW. Rogers SJ, et al. Among authors: kreuwel ht. Arch Surg. 2010 Jan;145(1):28-33. doi: 10.1001/archsurg.2009.226. Arch Surg. 2010. PMID: 20083751 Clinical Trial.

4

The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigen.

Redmond WL, Wei CH, Kreuwel HT, Sherman LA. Redmond WL, et al. Among authors: kreuwel ht. J Immunol. 2008 Apr 15;180(8):5275-82. doi: 10.4049/jimmunol.180.8.5275. J Immunol. 2008. PMID: 18390708 Free PMC article.

5

Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetes.

Gadkar KG, Shoda LK, Kreuwel HT, Ramanujan S, Zheng Y, Whiting CC, Young DL. Gadkar KG, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2007 Apr;1103:63-8. doi: 10.1196/annals.1394.013. Epub 2007 Mar 21. Ann N Y Acad Sci. 2007. PMID: 17376835

6

The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.

Zheng Y, Kreuwel HT, Young DL, Shoda LK, Ramanujan S, Gadkar KG, Atkinson MA, Whiting CC. Zheng Y, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2007 Apr;1103:45-62. doi: 10.1196/annals.1394.014. Epub 2007 Mar 21. Ann N Y Acad Sci. 2007. PMID: 17376834

7

Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes.

Young DL, Ramanujan S, Kreuwel HT, Whiting CC, Gadkar KG, Shoda LK. Young DL, et al. Among authors: kreuwel ht. Ann N Y Acad Sci. 2006 Oct;1079:369-73. doi: 10.1196/annals.1375.057. Ann N Y Acad Sci. 2006. PMID: 17130581

8

A comprehensive review of interventions in the NOD mouse and implications for translation.

Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. Shoda LK, et al. Among authors: kreuwel ht. Immunity. 2005 Aug;23(2):115-26. doi: 10.1016/j.immuni.2005.08.002. Immunity. 2005. PMID: 16111631 Free article. Review.

9

CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA. Martinez X, et al. Among authors: kreuwel ht. J Immunol. 2005 Aug 1;175(3):1677-85. doi: 10.4049/jimmunol.175.3.1677. J Immunol. 2005. PMID: 16034108

10

Memory CD8(+) T cells undergo peripheral tolerance.

Kreuwel HT, Aung S, Silao C, Sherman LA. Kreuwel HT, et al. Immunity. 2002 Jul;17(1):73-81. doi: 10.1016/s1074-7613(02)00337-0. Immunity. 2002. PMID: 12150893 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters